Corbus Pharmaceuticals still shows promise, with CRB-701 and CRB-601 advancing in clinical trials. Read why CRBP stock is ...

Thomas Smith, an analyst from Leerink Partners, reiterated the Buy rating on Cartesian Therapeutics (RNAC – Research Report). The ...

Following treatment with NUC-3373 plus pembrolizumab, the patient achieved 100% reduction in the target lesion (considered a confirmed Partial Response due to the presence of non-target lesions) and ...

Palantir’s multi-decade prowess in advanced mission-critical analytics is already making its AI genuinely valuable. Read why ...

The first edition of Freshwater Fishes of Southern Africa was published in 1993, followed by the second edition in 2001. With the release of the third edition in 2024, Skelton, who has devoted much of ...

California voters rejected the anti-slavery measure Proposition 6, which would have banned forced labor in state prisons.

Let’s take concrete action to protect the millions of US residents facing the threat of Trump’s deportation crosshairs.

DURHAM, N.C., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...

In 2024, the agency built on its strong foundations by welcoming 17 new clients, including the likes of the ABC, Dan Murphy’s and Microsoft. All told, the agency grew its revenue by nearly half over ...

Indians are ambitious and self-confident today. There’s a palpable air of hope and optimism all over the country. Thousands of Adanis and Ambanis are in the making. Driven by a diverse population, a ...

By Ben Aris in Berlin A pall of anticipated disappointment hangs over the COP29 UN climate summit that kicks off in Baku, the ...

Fans are waiting with bated breath for the Disney live-action remake of The Little Mermaidand not just because the 1989 film remains a favorite ... is one of the few human characters; the rest of the ...